134
Views
5
CrossRef citations to date
0
Altmetric
Research Article

9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells

, , , , , & show all
Pages 269-291 | Received 12 Nov 2020, Accepted 14 Feb 2021, Published online: 09 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rajesh Kumar Meher, Showkat Ahmad Mir & Siva Shanker Anisetti. (2023) In silico and in vitro investigation of dual targeting Prima-1MET as precision therapeutic against lungs cancer. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now
Pratyush Pragyandipta, Rajesh Kumar Meher, Praveen Kumar Reddy, Ravikumar Pedaparti, Srinivas Kantevari & Pradeep K. Naik. (2022) Structure Based Design of Tubulin Binding 9-Arylimino Noscapinoids: Chemical Synthesis and Experimental Validation Against Breast Cancer Cell Lines. Analytical Chemistry Letters 12:1, pages 29-43.
Read now

Articles from other publishers (3)

Sanjay Kumar, Bulbul Sagar, Abhay Gaur, Shefali Shukla, Ekta Pandey & Shikha Gulati. (2023) Insight into the Tubulin-Targeted Anticancer Potential of Noscapine and its Structural Analogs. Anti-Cancer Agents in Medicinal Chemistry 23:6, pages 624-641.
Crossref
Helena Pérez-Peña, Anne-Catherine Abel, Maxim Shevelev, Andrea E. Prota, Stefano Pieraccini & Dragos Horvath. (2023) Computational Approaches to the Rational Design of Tubulin-Targeting Agents. Biomolecules 13:2, pages 285.
Crossref
Dongliang Zhang, Fusong Wu, Zhijian Wan, Yichun Wang, Xuan He, Bing Guo, Hengzhi You & Fen-Er Chen. (2022) A palladium polyaniline complex: a simple and efficient catalyst for batch and flow Suzuki–Miyaura cross-couplings. Chemical Communications 58:77, pages 10845-10848.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.